Stent coated with magnesium-based compound for reducing...

Details Stent coated with magnesium-based compound for reducing... Stent coated with magnesium-based compound for reducing...

2003-12-24

2008-11-18

DeSanto, Matthew F (Department: 3763)

Prosthesis (i.e., artificial body members), parts thereof, or ai

Arterial prosthesis

Drug delivery

C623S001460

Reexamination Certificate

active

07452373

ABSTRACT:
Treatment with magnesium produces a inhibition of acute stent thrombosis under high-shear flow conditions without any hemostatic or significant hemodynamic complications.

REFERENCES:
patent: 4182774 (1980-01-01), Welstead, Jr. et al.
patent: 5837313 (1998-11-01), Ding et al.
patent: 5849338 (1998-12-01), Richardson et al.
patent: 6042849 (2000-03-01), Richardson et al.
patent: 6071305 (2000-06-01), Brown et al.
patent: 6087373 (2000-07-01), Coburn et al.
patent: 6100297 (2000-08-01), Weglicki
patent: 6207218 (2001-03-01), Layrolle et al.
patent: 6287332 (2001-09-01), Bolz et al.
patent: 6709379 (2004-03-01), Brandau et al.
patent: 2000210380 (2000-08-01), None
patent: 00/45162 (2000-08-01), None
patent: PCT/GB00/00690 (2000-08-01), None
Toft et al., Intravenously and Topically Applied Magnesium in the Prevention of Arterial Thrombosis, Feb. 2000, Thrombosis Research 99 (2000) 61-69.
Somberg et al., Late Stent Thrombosis: Problem or Not?, The American Journal of Cardiology, (Apr. 1, 2007), 99(7), pp. 1020-1023.
Hara et al., Role Of Stent Design and Coatings On Restenosis and Thrombosis, Advanced Drug Delivery Reviews, (Jun. 3, 2006), 58(3), pp. 377-386.
Moussa et al., Matched Comparison Of Slotted Tubular and Coil Stents : Differences In Acute Gain, Loss Index, and Clinical Outcome, Heart Disease, (Mar.-Apr. 2000), 2(2), pp. 102-107 (Abstract Only).
Pieniazek et al., Clinical Outcomes In Patients After Single Vessel PTCA With Multiple Stent Implantation, Przegla•d Iekarski, 58(6), pp. 479-483 (Abstract Only).
Manolis, A.S., Reduced Incidence Of Clinical Restenosis With Newer Generation Stents, Stent Oversizing, and High-Pressure Deployment: Single-Operator Experience, Clinical Cardiology, (Feb. 2001), 24(2), pp. 119-126 (Abstract Only).
Rukshin, V., et al., “Intravenous Magnesium in Experimental Stent Thrombosis in Swine,” Ateriorscler Thromb Vasc Biol. 21(9):1544-49 (Sep. 2001).
Gertz, D.S., et al., “Effect of Magnesium Sulfate on Thrombus Formation following Partial Arterial Constriction: Implications for Coronary Vasospasm,” Magnesium. 6(5):225-35 (1987).
Claus, H-D., “Zur Frage der Wirksamkeit einer thromboembolieprophylaxe durch Magnesium bei der Kontakttherapie von Portio- und Korpuskarzinomen der Uterus mit Gammastrahlern,” Strahlentherapie, 135(3):291-94 (Mar. 1968) (Abstract in English).
Ravn, H.B., et al., “Magnesium Inhibits Platelet Activity—Infusion Study in Healthy Volunteers,” Thrombosis and Haemostasis. 75(6):939-44 (Jun. 1996).
www.americanheart.org, Angioplasty, Percutaneous Transluminal Coronary (PTCA), Mar. 23, 2001.
H.B. Ravn, et al., “Early Administration of Intravenous Magnesium Inhibits Arterial Thrombus Formation,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 17(12), 1997, pp. 3620-3625.
Michael Shechter et al., “Low intracellular magnesium levels promote platelet-dependent thrombosis in patients with coronary artery disease,” American Heart Journal, 140:212-218 (Aug. 2000).
Vladimir Rukshin et al, “Intravenous Magnesium in Experimental Stent Thrombosis in Swine,” Arteriosclerosis, Thrombosis and Vascular Biology, 21:1544-1549 (Sep. 2001).
S.D. Gertz et al., “Effect of Magnesium Sulfate on Thrombus Formation Following Partial Arterial Constriction: Complications for Coronary Vasospasm,” Magnesium, vol. 6, No. 5, pp. 225-235 (1987).
H-D Claus, “Zur Frage der Wirksamkeit einer Thromboembolieprophylaxe durch Magnesium bei der Kontakttherapie von Portio- und Korpuskarzinomen der Uterus mit.Gammastrahlern,” Strahlentherapie, vol. 135, No. 3, pp. 291-294 (1968).
H.B. Ravn et al., “Magnesium Inhibits Platelet Activity—an infusion study in healthy volunteers,” Thrombosis and Haemostasis, vol. 75, No. 6, pp. 939-944 (1996).
Vladimir Rukshin et al, “Comparative Antithrombotic Effects of Magnesium Sulfate and the Platelet Glycoprotein IIb/IIIa Inhibitors Tirofiban and Eptifibatide in a Canine Model of Stent Thrombosis,” Circulation, vol. 105, pp. 1970-1975 (2002).

Affiliated with

Also associated with

Rating

Stent coated with magnesium-based compound for reducing... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Stent coated with magnesium-based compound for reducing..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stent coated with magnesium-based compound for reducing... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4048609